Yang has deep experience representing leading issuers and investment banks in capital market transactions, with a focus on IPOs, including headline-making first HKEX deals for pre-revenue biotech companies, dual-class share structures, SPAC listings and secondary listings. After the IPO, Yang is a trusted adviser to HKEX-listed companies on complex disclosure, compliance and corporate governance issues.

His experience in debt capital markets covers the spectrum, from high-yield and credit-enhanced bond offerings and private placements to multi-billion-dollar debt programmes for China’s leading corporates.

Yang also advises leading Chinese corporates and global PE funds on cross-border investments and acquisitions, including Hong Kong public takeovers. He is the co-author of the Hong Kong chapter of Getting the Deal Through: Private M&A.

A client quoted by Chambers says Yang is “highly capable and experienced as an individual, especially when dealing with complicated transactions.”